Key facts
- It has raised $25.6M.
- Notable investors include Innovate UK, Techstart Ventures, The Scottish National Investment Bank, Archangel Investors, Association of British Healthtech Industries — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for iGii
- ·The full record, as it builds
Funding rounds
No funding rounds for iGii are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iGii
Developer of a 3D graphene foam designed to produce foam directly onto any surface, at room temperature, and in seconds. The company offers foam that is customizable, scalable into the electrochemically active surface area and supercapacitor with fast charging, power, and lifetime battery life, enabling manufacturers to remove the cost, variability, and stability issues inherent in the process.
- Sector
- Business Products and Services (B2B)
- HQ
- Stirling, United Kingdom
- Founded
- 2016
- Employees
- 57
- Website
- igii.uk/
- Ownership
- Privately Held (backing)
iGii doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iGii shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iGii in its N-PORT filings yet. We sweep new filings monthly.